

2018 Cosbie Lecture
Canadian Cancer Trials Group Annual Spring Meeting of Participants
28 April 2018
Toronto, Ontario
Sponsored By: Canadian Oncology Societies / Cancer Care Ontario / Canadian Cancer Trials Group
CRAIG EARLE, MD, MSc, FRCPC
How Can We Introduce Innovative Treatments into our Publicly-Funded Healthcare System?

Dr. Earle originally trained and practiced in Ottawa, after which, beginning in 1998, he spent 10 years in Boston at Harvard Medical School and the Harvard School of Public Health. Between 2008-2017, he was Director of Health Services Research and Head of Clinical Translation at the Ontario Institute for Cancer Research.
Dr. Cosbie was born in Toronto on January 29, 1894. He was educated at Upper Canada College as card card-body bg-light well as the University of Toronto Medical School. After graduating in 1915, he joined the Royal Canadian Army Medical Corps. He served with the Third Canadian Division and was wounded at Vimy Ridge. His distinguished service saw him awarded the Military Cross for outstanding bravery.
Upon his return to Canada in 1919, he undertook graduate studies and became a Fellow of the Royal College of Surgeons of Canada, as card card-body bg-light well as a Fellow of the Royal College of Obstetricians and Gynaecologists. He pioneered and refined certain treatments for gynaecological cancer. On September 13, 1921, he cared for the first patients who were treated with radiotherapy at the Toronto General Hospital (TGH).
Dr. Cosbie was a gynaecological consultant at the Ontario Institute of Radiotherapy at the TGH when his colleague, Dr. Gordon Richards, died in 1949. Despite the demands of a busy practice and lecturing and clinical commitments at the University of Toronto and at the TGH, Dr. Cosbie stepped in to fill the void left by Dr. Richards. Dr. Cosbie succeeded him as a member of the Ontario Cancer Treatment and Research Foundation, as Chairman of the Advisory Medical Board and its Executive Committee. He also played an important role in discussions with the provincial government, ultimately leading to the establishment of the Ontario Cancer Institute.
He retired from the staff of the university in 1954 and accepted the post of Medical Director of the Foundation, on a part-time basis. Dr. Cosbie had unofficially been performing these duties since 1949. The position became full-time once he retired from his private practice.
In 1957 Dr. Cosbie became Vice-chairman of the Foundation, a post he held until 1971.
On June 30, 1965, Dr. Cosbie stepped down from his post as Medical Director. Under his vigorous and able leadership, many new programs had been introduced and existing programs improved and expanded. He was an entertaining raconteur, a fluent speaker, and a skilled writer, making him an excellent representative of the Foundation and a strong proponent of its work. In 1973, after moving to Vancouver, Dr. Cosbie resigned from the Board after serving the Foundation and the Advisory Medical Board committees for many years.
The first Cosbie Lecture, which was awarded to the newly-formed Canadian Oncology Society, was delivered on January 27, 1977 in Toronto, by Mr. Basil Morson, the distinguished pathologist of St. Mark’s Hospital in London, England. Dr. Cosbie was on hand for the occasion.
Year | Lecturer | |
---|---|---|
2017 | Dr. Gerald Batist Toronto, ON |
Precision Medicine Requires Precise Targets and a Community of Patients |
2016 | Dr. Mary Gospodarowicz Toronto, ON |
Global Cancer Control - Challenges and Opportunities |
2015 | Dr. Joseph M. Connors Vancouver, BC |
Yin and Yang: Population-Based Studies and Clinical Trials – Lessons from Lymphoid Cancer |
2014 | Dr. Ian Tannock Toronto, ON |
Whither (or Wither?) the Randomised Clinical Trial? |
2013 | Dr. Elizabeth Eisenhauer Kingston, ON |
Initiatives to Advance the State of Cancer Clinical Trials in Canada – Hope in Spring |
2012 | Dr. Robert Califf Durham, NC |
The American Clinical Trials Enterprise: Are We Reaching the Tipping Point for Transformation? |
2011 | Dr. Bernard Cummings Toronto, ON |
Radiation Therapy, Rectal Cancer and Clinical Trials: Lessons and Opportunities |
2010 | Dr. Hartley S. Stern Montreal, QC |
5 Year Survival of Clinical Cancer Trials in Canada: Perspective of a Lapsed Investigator |
2009 | Dr. Frances A. Shepherd Toronto, ON |
Lung Cancer: A Journey from Nihilism to Hope Through Bench to Bedside Research |
2008 | Dr. Kathleen Pritchard Toronto, ON |
Thirty Years of Breast Cancer Research in the NCIC CTG" or " How time flies when you're having fun" |
2007 | Dr. Joseph Pater Kingston, ON |
Clinical Research in Canada: Four Decades in Evolution |
2006 | Dr. George Browman Toronto, ON |
Five Steps: Introducing a Tool to Facilitate Resource Allocation Decisions About Cancer Care Drug Funding |
2004 | Dr. Anthony Fields Edmonton, AB |
Evolution of Cancer Advocacy in Canada |
2002 | Dr. Steven Gallinger Toronto, ON |
Impact of Genetics and Clinical Care of Patients and their Families |
Year | Lecturer |
---|---|
2001 | Dr. Charles Weijer - Halifax, NS |
2000 | Dr. John Potter - Seattle, WA |
1999 | Dr. Richard Bakemeier - Denver, CO |
1998 | Dr. David Osoba - Vancouver, BC |
1997 | Dr. Janet Rowley - Chicago, IL |
1998 | Dr. David Osoba - Vancouver, BC |
1997 | Dr. Janet Rowley - Chicago, IL |
1996 | Dr. Balfour Mount - Montreal, QC |
1995 | Dr. Henry Shibata - Montreal, QC |
1994 | Dr. Joseph Pater - Kingston, ON |
1993 | Dr. Jack Roth |
1992 | Dr. W. Thomas - Seattle, WA |
1991 | Dr. Alan Gerulath |
1990 | Dr. James H. Goldie - British Columbia |
1989 | Dr. James Cox - Houston, TX |
1988 | Dr. Charles Balch - Houston, TX |
1987 | Dr. David Schottenfeld - Ann Arbor, MI |
1986 | Dr. D.E. Bergsagel - Toronto, ON |
1985 | Dr. David Boyes - British Columbia |
1984 | Dr. Robert W. Bruce - Toronto, ON |
1983 | Dr. Oliver Beahrs - Rochester, MN |
1982 | Dr. R.B. Livingston |
1981 | Dr. Malcolm A. Bagshaw - California |
1980 | Dr. J.P. Smith - Detroit, MI |
1979 | Dr. E.L. Wynder - New York, NY |
1978 | Dr. Marvin Schneiderman - Washington, DC |
1977 | Mr. Basil Morson - London, England |